SMO Clinplus Co

SMO Clinplus Co EBIT Margin

The EBIT Margin (Operating Margin) of SMO Clinplus Co (301257.SZ) as of Nov 4, 2026 is 15.95 %. In the previous year, EBIT Margin (Operating Margin) was 14.32 % — a change of 11.35% (higher).

EBIT Margin

15.95 %

YoY

11.35%

Last updated:

EBIT Margin (Operating Margin) of SMO Clinplus Co is 2025 15.95 % . EBIT Margin (Operating Margin) of SMO Clinplus Co was 2024 14.32 % . It decreases by 11.35% higher compared to the previous year.

For SMO Clinplus Co, the operating (EBIT) margin of 16.0% is up versus 14.6% a few years ago.

The SMO Clinplus Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
20.14 CNY
Jan 1, 2020
13.99 CNY
Jan 1, 2021
14.58 CNY
Jan 1, 2022
13.54 CNY
Jan 1, 2023
20.40 CNY
Jan 1, 2024
14.32 CNY
Jan 1, 2025
15.95 CNY
The SMO Clinplus Co EBIT Margin history
YEAREBIT MarginYoY
15.95 %+11.35%
14.32 %-29.79%
20.40 %+50.69%
13.54 %-7.17%
14.58 %+4.23%
13.99 %-30.54%
20.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMO Clinplus Co Stock analysis

What does SMO Clinplus Co do? SMO ClinPlus Co., Ltd. generates revenue by offering site management organization (SMO) services for clinical research and development to pharmaceutical companies, medical device companies, and health-related product developers. The company provides comprehensive services including pre-preparation planning, site start-up, on-site execution, and full-process project management. Its primary clients are domestic and foreign pharmaceutical firms, medical device manufacturers, and health product R&D entities operating in both domestic and international markets. The firm's service model focuses on supporting clinical trials through end-to-end management, targeting companies engaged in drug development and medical device testing. By delivering tailored SMO solutions, SMO ClinPlus serves the needs of clients requiring efficient site management for their clinical research activities. The company's operations span across domestic and overseas markets, serving a broad range of healthcare industry participants. SMO Clinplus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMO Clinplus Co stock

EBIT Margin (Operating Margin) of SMO Clinplus Co is 15.95 % in 2025.

EBIT Margin (Operating Margin) of SMO Clinplus Co changed from 14.32 % to 15.95 %, representing a 11.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) SMO Clinplus Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s SMO Clinplus Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — SMO Clinplus Co

All Key Metrics — SMO Clinplus Co